Monitoring of TCR clonotype and diversity of CD8+PD-1+ T-cells in locally-advanced non-small cell lung cancer: A Biomarker Study.

Monitoring of TCR clonotype and diversity of CD8+PD-1+ T-cells in locally-advanced non-small cell lung cancer: A Biomarker Study. - TCR clonotype and diversity of CD8+PD-1+ T-cells in locally-advanced non-small cell lung cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045171

Enrollment

100

Registered

2021-08-18

Start date

2020-03-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

locally-advanced non-small cell lung cancer patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Locally adnced NSCLC patiens. 2) Treatment with CRT. 3) Written Informed consent

Exclusion criteria

Exclusion criteria: 1) Patients judged as inappropriate for the study by the investigator

Design outcomes

Primary

Measure	Time frame
To evaluate the TCR clonotype on CD8+PD-1+ T-cells during CRT	—

Countries

Japan

Contacts

Public ContactTatsuya Yoshida

National Cancer Center Hospital Department of thoracic oncology

tatyoshi@ncc.go.jp03-3542-2511

Outcome results